The Siteman Cancer Center at Barnes-Jewish Hospital and Washington School of Medicine in St. Louis has been accepted into The National Comprehensive Cancer Network (NCCN), an alliance of the world’s leading cancer centers. The designation will allow Siteman Cancer Center access to and the ability to further improve cancer care guidelines.
With this addition, NCCN now includes 20 centers dedicated to improving the quality, effectiveness and efficiency of oncology practice so patients can live better lives.
The Siteman Cancer Center has multidisciplinary programs for all types of cancer. Nearly 6,000 new cancer patients are treated there each year. The Siteman Cancer Center is a partnership of two nationally recognized organizations: Barnes-Jewish Hospital and Washington University School of Medicine. Barnes-Jewish Hospital ranks consistently among the top 10 hospitals nationally in U.S. News and World Report ratings, and in the same ratings, the School of Medicine routinely ranks among the top five medical schools.
In addition to treatment excellence, Siteman Cancer Center also provides access to clinical studies for all disease types and reaches out to over 30,000 people yearly with cancer screening and education programs.
“We welcome the Siteman Cancer Center to the NCCN. Siteman is recognized internationally as a leader in the development and delivery of high quality cancer care,” said William T. McGivney, PhD, Chief Executive Officer of NCCN. “Siteman will serve to geographically complement other NCCN members in our unique, premier network.”
“As an NCCN member, the Siteman Cancer Center will be involved in the planning, development, and validation of therapies that represent the future of cancer care. Oncologists at Siteman Cancer Center—medical, radiation, surgical oncologists—will not only contribute to the development of new protocols based upon the extensive basic and clinical research in cancer carried out here but will also bring other ideas back to Siteman Cancer Center, creating new avenues of investigation and innovative patient care,” said Timothy J. Eberlein, MD, Director. “Patients at Siteman Cancer Center will benefit from access to the most advanced clinical treatment protocols, receiving care from oncologists engaged in emerging technology, in a system dedicated to continuous quality improvement.”
Washington University School of Medicine’s full-time and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.